Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Today's price action

Would it not make sense to get the stock up to the minimum requirements and move to a higher exchange prior to the end of the trial?  Seems to me it would allow much more visibility and a higher based from which to begin its lift off.

 

I don't know, maybe it's just me.

Share
New Message
Please login to post a reply